Unified Protocol for Treatment of Emotional Disorders in Brief Groups in Primary Care Services in Spain
Study of the Cost-efficacy and Acceptability of the Unified Protocol for Treatment of Emotional Disorders in Brief Groups in Primary Care Services in Spain (PU-AP)
1 other identifier
interventional
180
1 country
1
Brief Summary
The aim of this project is to contribute to the improvement of psychological care received in primary care (PC), through the study of the cost-effectiveness and acceptability of the Unified Protocol for the treatment of emotional disorders in brief groups in primary care services in Spain (PU-AP) for the treatment of emotional disorders (EDs), the most prevalent in our society. To do so, a pilot study will be carried out, and, subsequently, a randomized clinical trial to study the efficacy, cost-effectiveness and acceptability of the Unified Protocol for the transdiagnostic treatment of EDs, applied in 5 or 8 group sessions. Finally, the researchers will analyze whether there are specific patient profiles that will benefit more from one or the other condition. The results will contribute to the personalization of the psychological treatment of users with EDs attending PC in the Spanish public health system.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started May 2025
Typical duration for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
August 7, 2024
CompletedFirst Posted
Study publicly available on registry
August 9, 2024
CompletedStudy Start
First participant enrolled
May 10, 2025
CompletedPrimary Completion
Last participant's last visit for primary outcome
September 1, 2026
ExpectedStudy Completion
Last participant's last visit for all outcomes
September 1, 2027
March 3, 2025
August 1, 2024
1.3 years
August 7, 2024
February 27, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (5)
Anxiety and Related Disorders Interview Schedule for DSM-5 (ADIS-V)
Diagnostic interview Diagnostic interview
Enrollment and Up to 6 months
Overall Depression Severity and Impairment Scale (ODSIS)
Consist of five items that evaluate the frequency and the intensity of depressive symptoms and their interference with the person's work or school life and social life. The total score range from 0 to 20 and responses use a 5-point Likert scale ranging from 0 to 4.
Up to 6 months
Overall Anxiety Severity and Impairment Scale (OASIS)
The scale presents five items. These items are related with the frequency and intensity of anxiety symptoms and their interference with the person's work or school life and with social life. All items are rated on a 5-point Likert scale ranging from 0 (I didn't feel anxious) to 4 (Constant anxiety).
Up to 6 months
Health-related quality of life (EuroQol-5D)
Evaluation through 5 items of quality of life. For this study, the visual analog scale (EQ-VAS) was used, using a score from 0 to 100 (0 = worst imaginable state of health; 100 = best imaginable state of health).
Up to 6 months
Difficulties in Emotion Regulation Scale (DERS)
Consists of 36-item of six facets of emotion regulation. Items are rated on a scale of 1 ("almost never \[0-10%\]") to 5 ("almost always \[91-100%\]"). Higher scores indicate more difficulty in emotion regulation
Up to 6 months
Secondary Outcomes (7)
The Multidimensional Emotional Disorder Inventory (MEDI)
Up to 6 months
Five Facet Mindfulness Questionnaire (FFMQ)
Up to 6 months
Working Alliance Inventory-Short (WAI-S)
Up to 6 months
Maladjustment Scale (MI)
Up to 6 months
Positive and negative affect scale
Up to 6 months
- +2 more secondary outcomes
Study Arms (2)
5-session UP condition
EXPERIMENTALIn both conditions, the contents of the UP manual were worked following the 2nd edition of the UP manual (Barlow et al., 2018). In the 5-session version, modules 1 (Motivation for change and commitment to treatment) and 8 (Achievement, maintenance, and relapse prevention) were removed and modules 6 and 7 (interoceptive and emotional exposure) were combined. The sessions were group sessions, 2 hours long and weekly.
8-session UP condition
ACTIVE COMPARATORIn both conditions, the contents of the UP manual were worked following the 2nd edition of the UP manual (Barlow et al., 2018). In the 8-session UP condition, each of the original 8 treatment modules was worked on per week. The sessions were group sessions, 2 hours long and weekly.
Interventions
Unified Protocol (UP) for transdiagnostic treatment of EDs in 5-session
Unified Protocol (UP) for transdiagnostic treatment of EDs in 8-session
Eligibility Criteria
You may qualify if:
- Have at least one EDs diagnosis (anxiety, depressive, obsessive-compulsive, trauma and somatic disorders) from the ADIS-5 interview
- Have a score between 0 and 5 severity (mild-moderate) on the diagnoses on the CSR of the ADIS-5
- Be able to attend all assessment and treatment sessions
- Individuals on pharmacological treatment will be asked to maintain the dosage for the duration of the study, unless there is a medical contraindication
You may not qualify if:
- Absence of clinical diagnosis
- Presenting a diagnosis of EDs with a severity score on diagnoses between 6 and 8 on the ADIS-5 CSR (severe) or a clinical condition requiring specialized mental health intervention such as presence of severe mental disorder (e.g., personality disorder, bipolar disorder, or schizophrenia), suicide risk at the time of assessment, or substance use in the past three months
- Who have received 8 or more sessions of CBT (during the past five years) with techniques such as cognitive flexibility or exposure
- Who are receiving psychological treatment.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Centro de Salud Carinyena, Hospital Universitario de La Plana
Villarreal, Valencia, 12540, Spain
Related Publications (2)
Barlow DH, Harris BA, Eustis EH, Farchione TJ. The unified protocol for transdiagnostic treatment of emotional disorders. World Psychiatry. 2020 Jun;19(2):245-246. doi: 10.1002/wps.20748. No abstract available.
PMID: 32394551BACKGROUNDPeris-Baquero O, Fadrique-Jimenez A, Prieto-Rollan I, Camacho-Guerrero L, Martinez-Lluesma S, Osma J. Brief Versions of the Unified Protocol for Transdiagnostic Treatment of Emotional Disorders in Spanish Primary Care Service: Results of a Feasibility Pilot Study. J Clin Psychol. 2025 Nov;81(11):1103-1117. doi: 10.1002/jclp.70016. Epub 2025 Jul 16.
PMID: 40667676DERIVED
Related Links
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Jorge Osma, Ph.D
Instituto de Investigación Sanitaria de Aragón, Universidad de Zaragoza
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- OUTCOMES ASSESSOR
- Masking Details
- Patients (participants) will know the treatment they have been assigned to. Healthcare professionals and researchers will know the condition each patient has been assigned to (mandatory to provide a given type of intervention).
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Principal Investigator
Study Record Dates
First Submitted
August 7, 2024
First Posted
August 9, 2024
Study Start
May 10, 2025
Primary Completion (Estimated)
September 1, 2026
Study Completion (Estimated)
September 1, 2027
Last Updated
March 3, 2025
Record last verified: 2024-08
Data Sharing
- IPD Sharing
- Will not share
Under request